Lee Ainslie - Maverick Capital
Holding/activity history for Thermo Fisher Scientific (TMO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q2 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2024 Q1 | 749 | 0.01 | Reduce 50.76% | 0.01 | $580.77 |
| 2023 Q4 | 1,521 | 0.02 | Add 94.25% | 0.01 | $530.57 |
| 2023 Q3 | 783 | 0.01 | Buy | 0.01 | $505.75 |
| 2021 Q3 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2021 Q2 | 876 | 0.00 | Reduce 63.42% | 0.00 | $504.57 |
| 2021 Q1 | 2,395 | 0.01 | Add 118.12% | 0.01 | $456.37 |
| 2020 Q4 | 1,098 | 0.01 | Buy | 0.01 | $465.39 |
| 2020 Q2 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2020 Q1 | 221 | 0.00 | Buy | 0.00 | $285.07 |
| 2019 Q4 | 0 | 0 | Sell 100.00% | 0.05 | |
| 2019 Q3 | 12,086 | 0.05 | Buy | 0.05 | $291.25 |
| 2019 Q2 | 0 | 0 | Sell 100.00% | 0.10 | |
| 2019 Q1 | 26,370 | 0.10 | Add 19.75% | 0.02 | $273.72 |
| 2018 Q4 | 22,020 | 0.07 | Add 94.35% | 0.03 | $223.80 |
| 2018 Q3 | 11,330 | 0.03 | Buy | 0.03 | $244.04 |